0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Breast Cancer
 1-20 of 616 Articles
JAMA Oncology | 
Invited Commentary |  FREE ONLINE FIRST
Sibylle Loibl, MD, PhD
JAMA Oncol. Published online April 30, 2015. doi:10.1001/jamaoncol.2015.0851

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Roberto Salgado, MD, PhD; Carsten Denkert, MD, PhD; Christine Campbell, MSc; et al.
JAMA Oncol. Published online April 30, 2015. doi:10.1001/jamaoncol.2015.0830
Includes: Supplemental Content

JAMA | 
Viewpoint | 
Robert P. Perrillo, MD; Paul Martin, MD; Anna S. Lok, MD
JAMA. 2015;313(16):1617-1618. doi:10.1001/jama.2015.2571.

JAMA Oncology | 
Editor's Note |  FREE ONLINE FIRST
Mary L. Disis, MD
JAMA Oncol. Published online April 23, 2015. doi:10.1001/jamaoncol.2015.0708

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Kelly Metcalfe, PhD; Henry T. Lynch, MD; William D. Foulkes, MBBS, PhD; et al.
JAMA Oncol. Published online April 23, 2015. doi:10.1001/jamaoncol.2015.0658

JAMA Oncology | 
Editorial |  FREE ONLINE FIRST
Purna A. Joshi, MSc, PhD; Pamela J. Goodwin, MD, MSc, FRCPC; Rama Khokha, PhD
JAMA Oncol. Published online April 16, 2015. doi:10.1001/jamaoncol.2015.0512

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Rowan T. Chlebowski, MD, PhD; Thomas E. Rohan, PhD; JoAnn E. Manson, MD, DrPH; et al.
JAMA Oncol. Published online April 16, 2015. doi:10.1001/jamaoncol.2015.0494
Includes: Supplemental Content

JAMA Oncology | 
JAMA Oncology Patient Page |  FREE ONLINE FIRST
Howard (Jack) West, MD
JAMA Oncol. Published online April 16, 2015. doi:10.1001/jamaoncol.2015.0671

JAMA Oncology | 
JAMA Oncology Clinical Challenge |  FREE ONLINE FIRST
Rajesh C. Rao, MD; Victor M. Elner, MD, PhD; Hakan Demirci, MD
JAMA Oncol. Published online April 09, 2015. doi:10.1001/jamaoncol.2015.0461

JAMA Oncology | 
Invited Commentary |  FREE ONLINE FIRST
Kimberly J. Van Zee, MS, MD
JAMA Oncol. Published online April 09, 2015. doi:10.1001/jamaoncol.2015.0390

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Ellie J. Coromilas, BA; Jason D. Wright, MD; Yongmei Huang, PhD, MPH; et al.
JAMA Oncol. Published online April 09, 2015. doi:10.1001/jamaoncol.2015.0389
Includes: Supplemental Content

JAMA | 
Original Investigation | 
Timothy R. Rebbeck, PhD; Nandita Mitra, PhD; Fei Wan, MS; et al.
JAMA. 2015;313(13):1347-1361. doi:10.1001/jama.2014.5985.
Includes: CME, Supplemental Content

JAMA Oncology | 
Brief Report |  FREE ONLINE FIRST
Ann H. Partridge, MD, MPH; Karen Sepucha, PhD; Anne O'Neill, MS; et al.
JAMA Oncol. Published online April 02, 2015. doi:10.1001/jamaoncol.2015.0246

JAMA Ophthalmology | 
JAMA Ophthalmology Clinical Challenge | 
Christina Y. Weng, MD, MBA; J. William Harbour, MD
JAMA Ophthalmol. 2015;133(4):473-474. doi:10.1001/jamaophthalmol.2014.5237.

JAMA Oncology | 
Original Investigation |  FREE
Samantha Hansford, MSc; Pardeep Kaurah, MSc; Hector Li-Chang, MD; et al.
JAMA Oncol. 2015;1(1):23-32. doi:10.1001/jamaoncol.2014.168.
Includes: CME, Supplemental Content

JAMA Oncology | 
Original Investigation |  FREE
Chenjie Zeng, MPH; Wanqing Wen, MD, MPH; Alicia K. Morgans, MD; et al.
JAMA Oncol. 2015;1(1):88-96. doi:10.1001/jamaoncol.2014.161.
Includes: Supplemental Content

JAMA | 
Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2015;313(12):1199. doi:10.1001/jama.2015.2195.

JAMA Oncology | 
Original Investigation |  FREE ONLINE FIRST
Rachel A. Freedman, MD, MPH; Elena M. Kouri, PhD; Dee W. West, PhD; et al.
JAMA Oncol. Published online March 19, 2015. doi:10.1001/jamaoncol.2015.20
Includes: Supplemental Content

JAMA | 
Editorial | 
Nancy E. Davidson, MD; David L. Rimm, MD, PhD
JAMA. 2015;313(11):1109-1110. doi:10.1001/jama.2015.1945.

JAMA | 
Original Investigation | 
Joann G. Elmore, MD, MPH; Gary M. Longton, MS; Patricia A. Carney, PhD; et al.
JAMA. 2015;313(11):1122-1132. doi:10.1001/jama.2015.1405.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
The Dual Role of Tumor-Infiltrating Lymphocytes in HER2-Positive Primary Breast Cancer:  Two Sides of the Same Coin?
Sibylle Loibl, MD, PhD
JAMA Oncology
Original Investigation  | 
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab:  A Secondary Analysis of the NeoALTTO Trial
Roberto Salgado, MD, PhD; Carsten Denkert, MD, PhD; Christine Campbell, MSc; et al.
JAMA
Viewpoint  | 
Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments
Robert P. Perrillo, MD; Paul Martin, MD; Anna S. Lok, MD
JAMA Oncology
Editor's Note  | 
Adjuvant Oophorectomy in the Treatment of Early-Stage BRCA Mutation–Positive Breast Cancer
Mary L. Disis, MD